Skip to content

A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)

A Registry Study of Biomarkers in Progression of Acute Heart Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04108182
Enrollment
850
Registered
2019-09-30
Start date
2015-12-31
Completion date
2025-10-31
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

heart failure

Brief summary

The registry study aims to discover the prognostic value of bio-markers in acute heart failure

Interventions

None listed

Sponsors

Beijing Institute of Heart, Lung and Blood Vessel Diseases
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* 1\. Patients aged greater than or equal to 18 years with acute exacerbation of chronic heart failure or new heart failure * 2\. With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling and fatigue (Limited activity endurance), increased jugular pressure, rales and peripheral edema ; * 3\. Plasma concentrations of BNP: BNP\>100pg/ML * 4\. Echocardiography: Related structural heart disease (left ventricular hypertrophy and/or left atrial enlargement) and/or diastolic dysfunction

Exclusion criteria

* 1\. Previous history of cancer or renal replacement therapy * 2.Surgery was performed within a month * 3.Accompanied by cardiogenic shock, sepsis, pneumonia * 4.Eligible patients without informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Number of death ( all cause) or readmission for heart failurea median follow-up of 8.8 monthsNumber of Death or heart failure related hospitalization within a median follow-up of 8.8 months of discharge

Secondary

MeasureTime frameDescription
Number of death ( all cause) or readmission for heart failure and cardiovascular mortalitya median follow-up of 8.8 monthsNumber of Death or heart failure related hospitalization and cardiovascular mortality within a median follow-up of 8.8 months of discharge

Countries

China

Contacts

Primary ContactYulin Li, PHD
lyllyl_1111@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026